On 3 September 2026, Kindstar Globalgene Technology, Inc. (KINDSTAR GLOBAL) repurchased 106,500 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 0.955 to HKD 0.995 per share, for a total consideration of approximately HKD 0.10 million (volume-weighted average price: HKD 0.9677).

Prior to the transaction, KINDSTAR GLOBAL had 1.03 billion issued shares excluding treasury stock and 8.72 million treasury shares. Post-repurchase, the number of shares in public hands decreased by 0.01 % to 1.03 billion, while treasury shares increased to 8.83 million. The company’s total issued share count remains unchanged at 1.04 billion.

The purchase was executed under the share repurchase mandate granted on 5 June 2026, which permits the company to buy back up to 103.43 million shares. Including the latest transaction, KINDSTAR GLOBAL has repurchased 1.76 million shares under this authority, representing 0.17 % of the shares outstanding on the mandate’s approval date.

In accordance with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 3 October 2026.